Rare diseases
Investigational molecules
Locations
Back to Poland37 clinical trials in Przemysl, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
PolandStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
PolandStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
PolandPolandStudy on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency
PolandStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
PolandA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
PolandEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
PolandStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
PolandStudy of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy
PolandPumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
PolandPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
PolandThe busiest research cities in the country
What the registry says about research in the country
Multiple innovative trials focusing on non-small cell lung cancer (NSCLC) treatments, combining novel therapeutic approaches with established treatments.
Studies are evaluating various treatment combinations to improve patient outcomes and survival rates.
Research focusing on myocardial infarction and related complications, including innovative treatments for heart failure and iron deficiency.
Trials aim to enhance recovery and reduce complications after heart attacks.
Investigation of pancreatic enzyme replacement therapy for patients who have undergone gastrectomy procedures.
Research focuses on improving nutritional outcomes after gastric surgery.
Studies examining treatments for hormone receptor-positive, HER2-negative breast cancer in postmenopausal women.
Trials evaluate new therapeutic combinations to enhance treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
